oculase ltd

Live YoungSmall

oculase ltd Company Information

Share OCULASE LTD

Company Number

12800648

Directors

Tariq Ayoub

Shareholders

tariq zeyad mohammad ayoub

Group Structure

View All

Industry

Specialist medical practice activities

 

Registered Address

221-223 wimbledon park road, london, SW18 5RH

Website

-

oculase ltd Estimated Valuation

£264.6k

Pomanda estimates the enterprise value of OCULASE LTD at £264.6k based on a Turnover of £617.4k and 0.43x industry multiple (adjusted for size and gross margin).

oculase ltd Estimated Valuation

£610.3k

Pomanda estimates the enterprise value of OCULASE LTD at £610.3k based on an EBITDA of £194.5k and a 3.14x industry multiple (adjusted for size and gross margin).

oculase ltd Estimated Valuation

£570.9k

Pomanda estimates the enterprise value of OCULASE LTD at £570.9k based on Net Assets of £236.7k and 2.41x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Oculase Ltd Overview

Oculase Ltd is a live company located in london, SW18 5RH with a Companies House number of 12800648. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in August 2020, it's largest shareholder is tariq zeyad mohammad ayoub with a 100% stake. Oculase Ltd is a young, small sized company, Pomanda has estimated its turnover at £617.4k with unknown growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Oculase Ltd Health Check

Pomanda's financial health check has awarded Oculase Ltd a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

4 Strong

positive_score

2 Regular

positive_score

3 Weak

size

Size

annual sales of £617.4k, make it larger than the average company (£376.1k)

£617.4k - Oculase Ltd

£376.1k - Industry AVG

growth

Growth

There is insufficient data available for this Key Performance Indicator!

- - Oculase Ltd

- - Industry AVG

production

Production

with a gross margin of 32%, this company has a higher cost of product (54.7%)

32% - Oculase Ltd

54.7% - Industry AVG

profitability

Profitability

an operating margin of 31.5% make it more profitable than the average company (14.3%)

31.5% - Oculase Ltd

14.3% - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (9)

2 - Oculase Ltd

9 - Industry AVG

paystructure

Pay Structure

on an average salary of £30.4k, the company has an equivalent pay structure (£30.4k)

£30.4k - Oculase Ltd

£30.4k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £308.7k, this is more efficient (£73.6k)

£308.7k - Oculase Ltd

£73.6k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 166 days, this is later than average (35 days)

166 days - Oculase Ltd

35 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 39 days, this is close to average (40 days)

39 days - Oculase Ltd

40 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Oculase Ltd

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Oculase Ltd

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 17.3%, this is a lower level of debt than the average (31.4%)

17.3% - Oculase Ltd

31.4% - Industry AVG

OCULASE LTD financials

EXPORTms excel logo

Oculase Ltd's latest turnover from August 2023 is estimated at £617.4 thousand and the company has net assets of £236.7 thousand. According to their latest financial statements, Oculase Ltd has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Aug 2023Aug 2022Aug 2021
Turnover617,434200,637121,462
Other Income Or Grants000
Cost Of Sales419,868126,49181,441
Gross Profit197,56674,14640,021
Admin Expenses3,10713,695-11,690
Operating Profit194,45960,45151,711
Interest Payable000
Interest Receivable000
Pre-Tax Profit194,45960,45151,711
Tax-48,615-11,486-9,825
Profit After Tax145,84448,96541,886
Dividends Paid000
Retained Profit145,84448,96541,886
Employee Costs60,81354,04927,421
Number Of Employees221
EBITDA*194,45960,45151,711

* Earnings Before Interest, Tax, Depreciation and Amortisation

Aug 2023Aug 2022Aug 2021
Tangible Assets4,0672,6860
Intangible Assets000
Investments & Other000
Debtors (Due After 1 year)000
Total Fixed Assets4,0672,6860
Stock & work in progress000
Trade Debtors282,182104,40056,976
Group Debtors000
Misc Debtors000
Cash000
misc current assets000
total current assets282,182104,40056,976
total assets286,249107,08656,976
Bank overdraft000
Bank loan000
Trade Creditors 45,27615,71014,715
Group/Directors Accounts000
other short term finances000
hp & lease commitments000
other current liabilities000
total current liabilities45,27615,71014,715
loans000
hp & lease commitments000
Accruals and Deferred Income4,278525375
other liabilities000
provisions000
total long term liabilities4,278525375
total liabilities49,55416,23515,090
net assets236,69590,85141,886
total shareholders funds236,69590,85141,886
Aug 2023Aug 2022Aug 2021
Operating Activities
Operating Profit194,45960,45151,711
Depreciation000
Amortisation000
Tax-48,615-11,486-9,825
Stock000
Debtors177,78247,42456,976
Creditors29,56699514,715
Accruals and Deferred Income3,753150375
Deferred Taxes & Provisions000
Cash flow from operations1,3812,6860
Investing Activities
capital expenditure-1,381-2,6860
Change in Investments000
cash flow from investments-1,381-2,6860
Financing Activities
Bank loans000
Group/Directors Accounts000
Other Short Term Loans 000
Long term loans000
Hire Purchase and Lease Commitments000
other long term liabilities000
share issue000
interest000
cash flow from financing000
cash and cash equivalents
cash000
overdraft000
change in cash000

oculase ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for oculase ltd. Get real-time insights into oculase ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Oculase Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for oculase ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in SW18 area or any other competitors across 12 key performance metrics.

oculase ltd Ownership

OCULASE LTD group structure

Oculase Ltd has no subsidiary companies.

Ultimate parent company

OCULASE LTD

12800648

OCULASE LTD Shareholders

tariq zeyad mohammad ayoub 100%

oculase ltd directors

Oculase Ltd currently has 1 director, Mr Tariq Ayoub serving since Aug 2020.

officercountryagestartendrole
Mr Tariq AyoubEngland41 years Aug 2020- Director

P&L

August 2023

turnover

617.4k

+208%

operating profit

194.5k

0%

gross margin

32%

-13.41%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

August 2023

net assets

236.7k

+1.61%

total assets

286.2k

+1.67%

cash

0

0%

net assets

Total assets minus all liabilities

Similar Companies

Similar companies unavailable for this selection

oculase ltd company details

company number

12800648

Type

Private limited with Share Capital

industry

86220 - Specialist medical practice activities

incorporation date

August 2020

age

5

incorporated

UK

ultimate parent company

None

accounts

Micro-Entity Accounts

last accounts submitted

August 2023

previous names

N/A

accountant

-

auditor

-

address

221-223 wimbledon park road, london, SW18 5RH

Bank

-

Legal Advisor

-

oculase ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to oculase ltd.

oculase ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for OCULASE LTD. This can take several minutes, an email will notify you when this has completed.

oculase ltd Companies House Filings - See Documents

datedescriptionview/download